3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
23
Breast Neoplasms
22
Carcinoma, Non-Small-Cell Lung
17
Rectal Neoplasms
13
Prostatic Neoplasms
13
Gliosarcoma
12
Lung Neoplasms
10
Head and Neck Neoplasms
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Neoplasms
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Adenocarcinoma Of Esophagus
8
Sarcoma
7
Neoplasm Metastasis
7
Central Nervous System Neoplasms
7
Pancreatic Neoplasms
6
Melanoma
6
Glioma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Burkitt Lymphoma
5
Oropharyngeal Neoplasms
4
Medulloblastoma
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
Radiation
×
Clear all
No trials found.